
Tonix Pharmaceuticals Holding Investor Relations Material
Latest events

Q2 2025
18 Aug, 2025

Q1 2025
30 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tonix Pharmaceuticals Holding Corp
Access all reports
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing therapies for central nervous system disorders, rare diseases, and infectious diseases. The company’s pipeline includes treatments for conditions such as post-traumatic stress disorder (PTSD), fibromyalgia, and long COVID. Tonix Pharmaceuticals also explores vaccine and antiviral drug candidates for infectious disease prevention and treatment. The company is headquartered in Chatham, New Jersey, and its shares are listed on the NASDAQ.
Key slides for Tonix Pharmaceuticals Holding Corp


Corporate Presentation
Tonix Pharmaceuticals Holding Corp


Investor Presentation
Tonix Pharmaceuticals Holding Corp
Latest articles
Ticker symbol
TNXP
Country
🇺🇸 United States